University Calendar
Approaches to Global Diseases
The Frugal Way to Meaningful Drug Development presented by Dr. Jerry Zeldis, Chief Medical Officer, Celgene Corporation and CEO, Celgene Global Health.
Celgene Global Health (CGH) collaborates with partners around the globe to find innovative solutions for healthcare challenges in the developing world.
Celgene has more than 400,000 compounds in our library across multiple platforms including immunomodulation, cell inhibition and cellular/tissue therapies. These platforms have potential applications to treat neglected diseases of the developing world (DDW) such as: Visceral Leishmaniasis (VL), Human African Trypanosomiasis (HA), Chagas Disease, Malaria and Lymphatic Filariasis. These diseases affect the most impoverished around the world. CGH is collaborating with Product Development Partnerships (PDPs), global academic institutions, including Montclair State, non-government organizations (NGOs), public/private funding organizations, contract research organizations (CROs), and other pharmaceutical organizations to evaluate our proprietary compounds for activity in neglected diseases.